Related Experiment Videos
A method to generate antigen-specific mAb capable of staining formalin-fixed, paraffin-embedded tissue sections
Xinhui Wang1, Michael Campoli, Hyun Suk Cho
1Department of Immunology, Roswell Park Cancer Institute, Buffalo, New York 14263, USA.
Journal of Immunological Methods
|May 18, 2005
Summary
Researchers developed a new method to create specific monoclonal antibodies (mAbs) for detecting antigen processing machinery (APM) components in cancer tissues. This breakthrough enables better analysis of APM expression in various conditions, aiding immunotherapy research.
Area of Science:
- Immunology
- Molecular Biology
- Oncology
Background:
- Abnormalities in HLA class I antigen expression are common in malignant tumors.
- Understanding these abnormalities is crucial for T cell-based immunotherapy outcomes.
- Antigen processing machinery (APM) component expression is one known mechanism, but limited research exists due to lack of suitable antibodies.
Purpose of the Study:
- To develop a method for generating monoclonal antibodies (mAbs) specific to APM components.
- To enable immunohistochemical (IHC) staining of formalin-fixed, paraffin-embedded tissues for APM components.
Main Methods:
- Synthesized peptides from APM components with low homology to mouse counterparts.
- Immunized mice with peptides and purified recombinant proteins.
- Generated hybridomas and screened for APM-specific antibody production using Western blotting.
- Characterized antibody specificity and reactivity via ELISA and flow cytometry.
- Tested antibody performance in IHC on formalin-fixed, paraffin-embedded tissues.
Main Results:
- Successfully generated a panel of APM component-specific mAbs.
- These mAbs effectively stain formalin-fixed, paraffin-embedded tissues in IHC reactions.
- The developed methodology is reproducible and straightforward.
Conclusions:
- The new method provides essential reagents for analyzing APM component expression in physiological and pathological tissues.
- This facilitates further research into HLA class I abnormalities and their role in cancer and immunotherapy.
- The methodology is adaptable for developing mAbs against other protein targets in fixed tissues.